TELA Bio, Inc.

Markets reinforced biologic tissue for hernia repair and plastic & reconstructive surgery.

TELA | NDAQ

Overview

Corporate Details

ISIN(s):: US8723811084
LEI:
Country:: United States of America
Address:: 1 GREAT VALLEY PARKWAY, SUITE 24, 19355 MALVERN
Website:: https://www.telabio.com/
Sector:: Manufacturing
Industry:: Manufacture of medical and dental instruments and supplies

Description

TELA Bio, Inc. is a commercial-stage medical technology company focused on designing, developing, and marketing innovative soft-tissue reconstruction solutions. The company's product portfolio is engineered to optimize clinical outcomes by leveraging a patient's natural healing response while minimizing exposure to permanent synthetic materials. Its core products, the OviTex® and OviTex® PRS Reinforced Tissue Matrices, are used in hernia repair, abdominal wall reconstruction, and plastic and reconstructive surgery. These solutions combine layers of ovine (sheep) biologic material with interwoven polymer sutures, creating a reinforced bioscaffold designed to facilitate tissue remodeling and provide a strong, yet less synthetic, alternative to traditional surgical mesh.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all TELA Bio, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for TELA Bio, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for TELA Bio, Inc. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Senseonics Holdings, Inc. Develops the first long-term, implantable glucose sensor for diabetes management.	United States of America	SENS
Sequana Medical N.V. Develops implantable devices to treat drug-resistant fluid overload from cirrhosis and heart failure.	Belgium	SEQUA
SEWOONMEDICAL CO,. LTD. Researches, develops, produces, and sells high-quality consumable medical products.	South Korea	100700
Sharps Technology Inc. Develops patented safety syringes for healthcare while managing a digital asset treasury.	United States of America	STSS
SHINECO, INC. A biotech firm developing stem cell tech, POCT diagnostics, and blockchain platforms.	United States of America	SISI
SHINHUNG CO.,LTD Global manufacturer of dental implants, alloys, and surgical kits for dental professionals.	South Korea	004080
SHOFU INC. Global manufacturer of dental materials, equipment, and nail care products for dental professionals.	Japan	7979
SHOULDER INNOVATIONS, INC. Develops advanced shoulder arthroplasty implant systems for surgeons in hospitals and ASCs.	United States of America	SI
SI-BONE, Inc. Develops MIS implants for sacroiliac joint dysfunction causing chronic low back pain.	United States of America	SIBN
Sight Sciences, Inc. Develops interventional ophthalmic solutions like the OMNI® Surgical System for glaucoma.	United States of America	SGHT